StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Are we dead in the water here?

<< Previous

Bullboard Posts

Next >>

Comment by TrippinAgain01on Jan 17, 2023 11:07am

117 Views

Post# 35227943

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Are we dead in the water here?

First EXAS sucks, now the pumping patriol are actually trying to compare little bitty SZLS to them. Classic. EXAS and SZLS are total opposites. EXAS mergers were actually meaningful. Since SZLS aquired CARE and launched "Aristotle", revenue has been decreasing lol, how is this possible?

User image